Literature DB >> 29484521

Diagnosis of non-osseous spinal metastatic disease: the role of PET/CT and PET/MRI.

Ali Batouli1, John Braun2, Kamal Singh2, Ali Gholamrezanezhad3, Bethany U Casagranda2, Abass Alavi4.   

Abstract

The spine is the third most common site for distant metastasis in cancer patients with approximately 70% of patients with metastatic cancer having spinal involvement. Positron emission tomography (PET), combined with computed tomography (CT) or magnetic resonance imaging (MRI), has been deeply integrated in modern clinical oncology as a pivotal component of the diagnostic work-up of patients with cancer. PET is able to diagnose several neoplastic processes before any detectable morphological changes can be identified by anatomic imaging modalities alone. In this review, we discuss the role of PET/CT and PET/MRI in the diagnostic management of non-osseous metastatic disease of the spinal canal. While sometimes subtle, recognizing such disease on FDG PET/CT and PET/MRI imaging done routinely in cancer patients can guide treatment strategies to potentially prevent irreversible neurological damage.

Entities:  

Keywords:  PET/CT; PET/MRI; Positron emissions tomography; Spinal cord; Spinal metastatic disease; Spinal tumor

Mesh：

Year:  2018        PMID： 29484521     DOI： 10.1007/s11060-018-2794-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  53 in total

1.  Intramedullary spinal cord metastasis from carcinoma of the lung: detection by positron emission tomography.

Authors:  M V Jayasundera; J F Thompson; M J Fulham
Journal:  Eur J Cancer       Date:  1997-03       Impact factor: 9.162

2.  Intramedullary Spinal Cord Metastasis from Breast Cancer Mimicking Delayed Radiation Myelopathy: Detection With (18)F-FDG PET/CT.

Authors:  Terufumi Kawamoto; Toshinari Yamashita; Satoshi Kaito; Yoshiharu Miura
Journal:  Nucl Med Mol Imaging       Date:  2015-06-12

3.  PET/MR Imaging: Clinical Applications.

Authors:  Drew A Torigian; Andreas Kjær; Habib Zaidi; Abass Alavi
Journal:  PET Clin       Date:  2016-10

4.  Leptomeningeal carcinomatosis and intramedullary spinal cord metastases from lung cancer: detection with FDG positron emission tomography.

Authors:  T Komori; D Delbeke
Journal:  Clin Nucl Med       Date:  2001-11       Impact factor: 7.794

Review 5.  Radiologic diagnosis of bone metastases.

Authors:  D I Rosenthal
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

6.  (18)F-FDG PET/CT for Diagnosis of Osteosclerotic and Osteolytic Vertebral Metastatic Lesions: Comparison with Bone Scintigraphy.

Authors:  Kenzo Uchida; Hideaki Nakajima; Tsuyoshi Miyazaki; Tatsuro Tsuchida; Takayuki Hirai; Daisuke Sugita; Shuji Watanabe; Naoto Takeura; Ai Yoshida; Hidehiko Okazawa; Hisatoshi Baba
Journal:  Asian Spine J       Date:  2013-05-22

7.  Spinal cord metastases from lung cancer: detection with F-18 FDG PET/CT.

Authors:  Nghi C Nguyen; Mohamed M Sayed; Khalid Taalab; Medhat M Osman
Journal:  Clin Nucl Med       Date:  2008-05       Impact factor: 7.794

8.  Leptomeningeal dissemination at diagnosis of pediatric low-grade neuroepithelial tumors.

Authors:  Juliette Hukin; Joao Siffert; Henry Cohen; Linda Velasquez; David Zagzag; Jeffrey Allen
Journal:  Neuro Oncol       Date:  2003-07       Impact factor: 12.300

9.  Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.

Authors:  Gerald Antoch; Florian M Vogt; Lutz S Freudenberg; Fridun Nazaradeh; Susanne C Goehde; Jörg Barkhausen; Gerlinde Dahmen; Andreas Bockisch; Jörg F Debatin; Stefan G Ruehm
Journal:  JAMA       Date:  2003-12-24       Impact factor: 56.272

Review 10.  False positive and false negative FDG-PET scans in various thoracic diseases.

Authors:  Jung Min Chang; Hyun Ju Lee; Jin Mo Goo; Ho-Young Lee; Jong Jin Lee; June-Key Chung; Jung-Gi Im
Journal:  Korean J Radiol       Date:  2006 Jan-Mar       Impact factor: 3.500
View more
  5 in total

Review 1.  Total-Body PET Imaging of Musculoskeletal Disorders.

Authors:  Abhijit J Chaudhari; William Y Raynor; Ali Gholamrezanezhad; Thomas J Werner; Chamith S Rajapakse; Abass Alavi
Journal:  PET Clin       Date:  2021-01

Review 2.  [18F]FDG-PET Evaluation of Spinal Pathology in Patients in Oncology: Pearls and Pitfalls for the Neuroradiologist.

Authors:  P Y Patel; I Dalal; B Griffith
Journal:  AJNR Am J Neuroradiol       Date:  2021-10-28       Impact factor: 3.825

3.  Magnetic Resonance Image under Variable Model Algorithm in Diagnosis of Patients with Spinal Metastatic Tumors.

Authors:  Hongliang Chen; Biao Xie; Xin Zhong; Xiang Ma
Journal:  Contrast Media Mol Imaging       Date:  2021-08-16       Impact factor: 3.161

Review 4.  State-of-the-Art Imaging Techniques in Metastatic Spinal Cord Compression.

Authors:  Tricia Kuah; Balamurugan A Vellayappan; Andrew Makmur; Shalini Nair; Junda Song; Jiong Hao Tan; Naresh Kumar; Swee Tian Quek; James Thomas Patrick Decourcy Hallinan
Journal:  Cancers (Basel)       Date:  2022-07-05       Impact factor: 6.575

Review 5.  Multimodal Molecular Imaging: Current Status and Future Directions.

Authors:  Min Wu; Jian Shu
Journal:  Contrast Media Mol Imaging       Date:  2018-06-05       Impact factor: 3.161
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.